|
|
|
|
| LEADER |
00000cam a22000004a 4500 |
| 001 |
mig00004637696 |
| 005 |
20071206094055.0 |
| 008 |
070427s2007 njua b 001 0 eng |
| 010 |
|
|
|a 2007017891
|
| 016 |
7 |
|
|a 101305787
|2 DNLM
|
| 020 |
|
|
|a 9780471752158 (cloth)
|
| 020 |
|
|
|a 0471752150 (cloth)
|
| 035 |
|
|
|a (OCoLC)ocn123962939
|
| 035 |
|
|
|a (OCoLC)123962939
|
| 035 |
0 |
0 |
|a ocn123962939
|
| 040 |
|
|
|a DNLM/DLC
|c DLC
|d NLM
|d BAKER
|d BTCTA
|d C#P
|d YDXCP
|
| 042 |
|
|
|a pcc
|
| 049 |
|
|
|a TXMM
|
| 050 |
0 |
0 |
|a RS420
|b .A79 2007
|
| 060 |
0 |
0 |
|a 2007 I-450
|
| 060 |
1 |
0 |
|a QV 744
|b A784 2007
|
| 082 |
0 |
0 |
|a 615/.19
|2 22
|
| 092 |
|
|
|a 615.19
|b Ar7
|
| 245 |
0 |
4 |
|a The art of drug synthesis /
|c edited by Douglas S. Johnson, Jie Jack Li.
|
| 260 |
|
|
|a Hoboken, N.J. :
|b Wiley-Interscience,
|c c2007.
|
| 300 |
|
|
|a xv, 276 p. :
|b ill. ;
|c 26 cm.
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 505 |
0 |
|
|a The role of medicinal chemistry in drug discovery / John A. Lowe III -- Process research: how much? how soon? / Neal G. Anderson -- Aromatase inhibitors for breast cancer : exemestane (Aromasin), anastrozole (Arimidex), and letrozole (Femara) / Jie Jack Li -- Quinolone antibiotics : levofloxacin (Levaquin), moxifloxacin (Avelox), gemifloxacin (Factive), and garenoxacin (T-3811) / Chris Limberakis -- Triazole antifungals : itraconazole (Sporanox), fluconazole (Diflucan), voriconazole (Vfend), and fosfluconazole (Prodif) / Andrew S. Bell -- Non-nucleoside HIV reverse transcriptase inhibitors / Arthur Harms -- Neuraminidase inhibitors for influenza : oseltamivir phosphate (Tamiflu) and zanamivir (Relenza) / Douglas S. Johnson and Jie Jack Li -- Peroxisome proliferator-activated receptor (PPAR) agonists for type 2 diabetes / Jin Li -- Angiotensin AT1 antagonists for hypertension / Larry Yet -- Leading ACE inhibitors for hypertension / Victor J. Cee and Edward J. Olhava -- Dihydropyridine calcium channel blockers for hypertension / Daniel P. Christen -- Second-generation HMG-CoA reductase inhibitors / Jeffrey A. Pfefferkorn -- Cholesterol absorption inhibitors: ezetimibe (zetia) / Stuart B. Rosenblum -- Dual selective serotonin and norepinephrine reuptake inhibitors (SSNRIs) for depression / Marta Pi䮥iro-Nⵤnez -- GABA receptor agonists for insomnia : zolpidem (Ambien), zaleplon (Sonata), eszopiclone (Estorra, Lunesta), and indiplon / Peter R. Guzzo -- Ligands: neurontin (Gabapentin) and lyrica (Pregabalin) / Po-Wai Yuen -- Approved treatments for attention deficit hyperactivity disorder : amphetamine (Adderall), methylphenidate (Ritalin), and atomoxetine (Straterra) / David L. Gray.
|
| 650 |
|
0 |
|a Drugs
|x Design.
|
| 650 |
|
0 |
|a Pharmaceutical chemistry.
|
| 700 |
1 |
|
|a Johnson, Douglas S.
|q (Douglas Scott),
|d 1968-
|
| 700 |
1 |
|
|a Li, Jie Jack.
|
| 907 |
|
|
|a 1560651
|b 07-17-10
|c 05-24-10
|
| 998 |
|
|
|a w
|b 06-18-10
|c m
|d a
|e -
|f eng
|g nju
|h 4
|i 1
|
| 935 |
|
|
|a 738934
|
| 907 |
|
|
|a 1560651
|b 06-06-10
|c 05-24-10
|
| 956 |
4 |
1 |
|a http://www.loc.gov/catdir/toc/ecip0717/2007017891.html
|3 Table of contents only
|
| 956 |
4 |
2 |
|a http://www.loc.gov/catdir/enhancements/fy0739/2007017891-b.html
|3 Contributor biographical information
|
| 956 |
4 |
2 |
|a http://www.loc.gov/catdir/enhancements/fy0739/2007017891-d.html
|3 Publisher description
|
| 994 |
|
|
|a C0
|b TXM
|
| 945 |
|
|
|a 615.19
|b Ar7
|g 1
|i 33082016431610
|j 0
|l w4
|o -
|p $89.95
|q -
|r -
|s -
|t 0
|u 8
|v 1
|w 0
|x 3
|y .i19147661
|z 05-25-10
|
| 999 |
f |
f |
|i 663e980b-8b74-4f86-81be-c423ead5b87f
|s aef9393e-6753-461b-8111-191818ad8c3b
|t 0
|
| 952 |
f |
f |
|p Circulating
|a Middle Tennessee State University
|b Main
|c James E. Walker Library
|d Main Collection - Walker Library - 4th Floor
|t 0
|e 615.19 Ar7
|h Library of Congress classification
|i Book
|m 33082016431610
|n 1
|
